MARS: The why and how of it

Abstract

The Multicenter ACL Revision Study (MARS Group) was assembled to address the issue of worse outcomes noted for revision ACL reconstructions noted by clinicians. It currently involves 83 surgeons at 52 sites which represents the most sites ever involved in a prospective orthopedic study. Greater than 1200 patients were enrolled, and 2-year follow-up has been completed at better than 80%. As described in this chapter, we have analyzed graft choice, meniscus, articular cartilage, surgical factors, rehabilitation factors, and their impact on outcome. The findings will allow us to counsel and treat patients more appropriately moving forward.